NEW YORK, July 16, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent,
NEW YORK, July 15, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company
Data shows excretion of codeine in fingerprint sweat INBS’ System is viable option for non-invasive diagnostic testing NEW YORK, July
Understanding drug test detection times is essential when choosing a testing method that aligns with your organization’s safety and compliance
With over 450 accounts across 24 countries, INBS continues to advance the evolution of drug screening technology NEW YORK, June
Employers are rethinking their approach to drug screening. Traditional tests, like urine and saliva, have been the standard for years,
NEW YORK, June 18, 2025 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent,
Many drug testing programs rely on urine or saliva collection, often chosen because they appear inexpensive. But what looks affordable
SMARTOX has deployed over 50 of INBS’ Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests, including more
Accuracy isn’t the only factor that matters when selecting a drug test for your work. You need a testing solution that
Random drug testing is vital to safety and compliance policies in many industries, from construction and manufacturing to transport and
INBS to participate with U.S. distribution partner SMARTOX at RISE25, the leading U.S. conference on addiction, mental health, and justice
Completion of 160 tests conducted in less than 90 minutes demonstrates a level of speed and efficiency beyond the limits
As workplace safety and compliance standards rise, more organizations are evaluating how drug testing is conducted and when it can
Company surpasses 450 accounts across 24 countries as global demand for fingerprint drug testing surges NEW YORK, May 15, 2025
